Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
[SINGAPORE] Luye Pharma Group Ltd, a Chinese drugmaker backed by Singapore's sovereign wealth fund, and existing owners are seeking to raise as much as US$764 million from a Hong Kong initial public offering.
The company and its investors are selling 999.6 million shares at HK$5.38 to HK$